These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 37074853)
21. Long-term lamotrigine plus lithium for bipolar disorder: One year outcome. Ghaemi SN; Schrauwen E; Klugman J; Berv DA; Shirzadi AA; Pardo TB; Goodwin FK J Psychiatr Pract; 2006 Sep; 12(5):300-5. PubMed ID: 16998417 [TBL] [Abstract][Full Text] [Related]
22. Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders. Serretti A; Lilli R; Lorenzi C; Franchini L; Di Bella D; Catalano M; Smeraldi E Psychiatry Res; 1999 Jul; 87(1):7-19. PubMed ID: 10512150 [TBL] [Abstract][Full Text] [Related]
23. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Perlis RH; Smoller JW; Ferreira MA; McQuillin A; Bass N; Lawrence J; Sachs GS; Nimgaonkar V; Scolnick EM; Gurling H; Sklar P; Purcell S Am J Psychiatry; 2009 Jun; 166(6):718-25. PubMed ID: 19448189 [TBL] [Abstract][Full Text] [Related]
24. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Rybakowski JK; Suwalska A; Skibinska M; Szczepankiewicz A; Leszczynska-Rodziewicz A; Permoda A; Czerski PM; Hauser J Pharmacopsychiatry; 2005 Jul; 38(4):166-70. PubMed ID: 16025419 [TBL] [Abstract][Full Text] [Related]
25. Lithium-related genetics of bipolar disorder. Detera-Wadleigh SD Ann Med; 2001 May; 33(4):272-85. PubMed ID: 11405549 [TBL] [Abstract][Full Text] [Related]
26. Response to lithium in bipolar disorder: clinical and genetic findings. Rybakowski JK ACS Chem Neurosci; 2014 Jun; 5(6):413-21. PubMed ID: 24625017 [TBL] [Abstract][Full Text] [Related]
27. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders. Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518 [TBL] [Abstract][Full Text] [Related]
29. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. Goodwin FK J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480 [TBL] [Abstract][Full Text] [Related]
30. Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder. Alda M; Grof P; Rouleau GA; Turecki G; Young LT Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1038-45. PubMed ID: 15946781 [TBL] [Abstract][Full Text] [Related]
31. Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients. Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Słopień A; Czerski PM; Leszczyńska-Rodziewicz A; Hauser J Pharmacol Rep; 2005; 57(6):761-5. PubMed ID: 16382194 [TBL] [Abstract][Full Text] [Related]
34. Association and linkage studies of candidate genes involved in GABAergic neurotransmission in lithium-responsive bipolar disorder. Duffy A; Turecki G; Grof P; Cavazzoni P; Grof E; Joober R; Ahrens B; Berghöfer A; Müller-Oerlinghausen B; Dvoráková M; Libigerová E; Vojtĕchovský M; Zvolský P; Nilsson A; Licht RW; Rasmussen NA; Schou M; Vestergaard P; Holzinger A; Schumann C; Thau K; Robertson C; Rouleau GA; Alda M J Psychiatry Neurosci; 2000 Sep; 25(4):353-8. PubMed ID: 11022400 [TBL] [Abstract][Full Text] [Related]
35. Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes. Rybakowski JK; Suwalska A; Skibinska M; Dmitrzak-Weglarz M; Leszczynska-Rodziewicz A; Hauser J Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):820-3. PubMed ID: 17373693 [TBL] [Abstract][Full Text] [Related]
36. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Rybakowski JK; Chlopocka-Wozniak M; Suwalska A Bipolar Disord; 2001 Apr; 3(2):63-7. PubMed ID: 11333064 [TBL] [Abstract][Full Text] [Related]
37. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP. Benedetti F; Serretti A; Pontiggia A; Bernasconi A; Lorenzi C; Colombo C; Smeraldi E Neurosci Lett; 2005 Mar; 376(1):51-5. PubMed ID: 15694273 [TBL] [Abstract][Full Text] [Related]
38. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks. Padiath QS; Paranjpe D; Jain S; Sharma VK Chronobiol Int; 2004 Jan; 21(1):43-55. PubMed ID: 15129823 [TBL] [Abstract][Full Text] [Related]